➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Express Scripts
Moodys
Johnson and Johnson
Harvard Business School

Last Updated: August 2, 2021

DrugPatentWatch Database Preview

BIMATOPROST Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

DrugPatentWatch® Litigation and Generic Entry Outlook for Bimatoprost

A generic version of BIMATOPROST was approved as bimatoprost by APOTEX INC on December 1st, 2014.

  Free Forever Trial

Drug patent expirations by year for BIMATOPROST
Drug Prices for BIMATOPROST

See drug prices for BIMATOPROST

Drug Sales Revenue Trends for BIMATOPROST

See drug sales revenues for BIMATOPROST

Recent Clinical Trials for BIMATOPROST

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
CBCC Global ResearchN/A
Mankind Pharma LimitedN/A
Medical University of South CarolinaEarly Phase 1

See all BIMATOPROST clinical trials

Pharmacology for BIMATOPROST
Medical Subject Heading (MeSH) Categories for BIMATOPROST
Paragraph IV (Patent) Challenges for BIMATOPROST
Tradename Dosage Ingredient NDA Submissiondate
LUMIGAN SOLUTION/DROPS;OPHTHALMIC bimatoprost 022184 2011-04-05
LATISSE SOLUTION/DROPS;TOPICAL bimatoprost 022369 2010-05-03
LUMIGAN SOLUTION/DROPS;OPHTHALMIC bimatoprost 021275 2008-12-22

US Patents and Regulatory Information for BIMATOPROST

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn BIMATOPROST bimatoprost SOLUTION/DROPS;OPHTHALMIC 203299-001 Nov 8, 2018 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Sandoz Inc BIMATOPROST bimatoprost SOLUTION/DROPS;OPHTHALMIC 202565-001 May 5, 2015 AT RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Gland Pharma Ltd BIMATOPROST bimatoprost SOLUTION/DROPS;OPHTHALMIC 210126-001 Mar 22, 2019 AT RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Express Scripts
Moodys
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.